BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22717078)

  • 1. Critical review of antipsychotic polypharmacy in the treatment of schizophrenia.
    Fleischhacker WW; Uchida H
    Int J Neuropsychopharmacol; 2014 Jul; 17(7):1083-93. PubMed ID: 22717078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
    Correll CU; Frederickson AM; Kane JM; Manu P
    Schizophr Res; 2007 Jan; 89(1-3):91-100. PubMed ID: 17070017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.
    Nosè M; Accordini S; Artioli P; Barale F; Barbui C; Beneduce R; Berardi D; Bertolazzi G; Biancosino B; Bisogno A; Bivi R; Bogetto F; Boso M; Bozzani A; Bucolo P; Casale M; Cascone L; Ciammella L; Cicolini A; Cipresso G; Cipriani A; Colombo P; Dal Santo B; De Francesco M; Di Lorenzo G; Di Munzio W; Ducci G; Erlicher A; Esposito E; Ferrannini L; Ferrato F; Ferro A; Fragomeno N; Parise VF; Frova M; Gardellin F; Garzotto N; Giambartolomei A; Giupponi G; Grassi L; Grazian N; Grecu L; Guerrini G; Laddomada F; Lazzarin E; Lintas C; Malchiodi F; Malvini L; Marchiaro L; Marsilio A; Mauri MC; Mautone A; Menchetti M; Migliorini G; Mollica M; Moretti D; Mulè S; Nicholau S; Nosè F; Occhionero G; Pacilli AM; Pecchioli S; Percudani M; Piantato E; Piazza C; Pontarollo F; Pycha R; Quartesan R; Rillosi L; Risso F; Rizzo R; Rocca P; Roma S; Rossattini M; Rossi G; Rossi G; Sala A; Santilli C; Saraò G; Sarnicola A; Sartore F; Scarone S; Sciarma T; Siracusano A; Strizzolo S; Tansella M; Targa G; Tasser A; Tomasi R; Travaglini R; Veronese A; Ziero S
    Trials; 2009 May; 10():31. PubMed ID: 19445659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium.
    Gagliano A; Masi G
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):595-8. PubMed ID: 19877988
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A; Accordini S; Nosè M; Purgato M; Girlanda F; Tansella M; Barbui C
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole augmentation for clozapine-associated tardive torticollis.
    Huang WL; Chang HC; Tsai YF; Chang LR; Liu CM
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E49. PubMed ID: 23224485
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.
    Stahl SM; Grady MM
    Curr Med Chem; 2004 Feb; 11(3):313-27. PubMed ID: 14965234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Di Nardo F; Santoro V; Spina E; Zoccali RA
    Schizophr Res; 2011 Apr; 127(1-3):93-9. PubMed ID: 21262565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.
    Andersen SE; Johansson M; Manniche C
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):75-81. PubMed ID: 18346047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data.
    Rajagopalan K; Hassan M; O'Day K; Meyer K; Grossman F
    J Med Econ; 2013 Jul; 16(7):951-61. PubMed ID: 23701260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clozapine on polypharmacy.
    Chong SA; Remington GJ; Bezchlibnyk-Butler KZ
    Psychiatr Serv; 2000 Feb; 51(2):250-2. PubMed ID: 10655014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.